This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rosen, R. H. Search for Related Content Social Bookmarking                         What's this?

Management of Chemotherapy-Induced Nausea and Vomiting

New York-Presbyterian Hospital, New York Weill Cornell Center, 525 E 68th St, New York, NY 10021, ror9020{at}nyp.org

Nausea and vomiting are among the most distressing adverse effects of cancer chemotherapy. They can lead to both physical and psychological complications if uncontrolled. The exact mechanism for chemotherapy-induced nausea and vomiting is not known; it is thought to occur through numerous neuronal pathways acting on different sites. Chemotherapy-induced nausea and vomiting are broken down into 3 phases: acute, delayed, and anticipatory. The incidence of each phase depends largely on the chemotherapy agent used and is primarily treated with different antiemetic agents. Pharmacists can assist in optimizing antiemetic use by selecting appropriate antiemetics based on the emetogenicity of the cancer treatment and helping to individualize therapy to each patient’s specific needs.

Key Words: nausea • vomiting • cancer chemotherapy • antiemetic agents

Journal of Pharmacy Practice, Vol. 15, No. 1, 32-41 (2002)
DOI: 10.1106/Y3FF-YGGF-26FD-XYDW


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?